Introduction
With the development of anti-tuberculosis chemotherapy, the incidence of tuberculosis had declined in the decades preceding the 1980s. However, endobronchial tuberculosis (EBTB) was observed in about 20% of patients with pulmonary tuberculosis who underwent bronchoscopy (1) . Some patients showed isolated endobronchial lesions without parenchymal tuberculosis (24). Recently, EBTB was reported in patients with AIDS (5).
The main clinical manifestations of EBTB are cough and sputum. However, 15-57% of EBTB patients have a localized or diffuse wheezing on Airway hyperresponsiveness to non-specific stimuli, such as histamine and methacholine, is a characteristic feature in symptomatic patients with bronchial asthma, and has been used in diagnosis (7,s). There are no data on airway responsiveness in EBTB. If EBTB patients show different responsiveness to bronchial provocation tests with histamine from bronchial asthma patients, non-specific bronchial provocation tests can be used for differential diagnosis in wheezy patients. In this study, airway responsiveness to histamine in patients with EBTB was compared with that in symptomatic bronchial asthma patients and normal, healthy controls. physical examination (24), which mimics bronchial asthma (6). In cases of EBTB with clinical manifesMethods tation of wheezing on physical examination and normal chest PA, differential diagnosis from bronchial asthma is frequently difficult. Non-invasive methods such as the chest roentgenogram and flowvolume loops are insensitive for detection of stenosis in EBTB (2). The definite diagnosis of EBTB can be made by fiberoptic bronchoscopy (6). However, fiberoptic bronchoscopy is not recommended as a diagnostic tool in symptomatic patients with bronchial asthma.
The study population were 15 patients with EBTB, 62 patients with bronchial asthma, and 35 healthy controls. All subjects gave informed consent before participation.
Wheezing was heard on the entire or localized lung field in all of the patients with EBTB and bronchial asthma. All patients with EBTB were initially suspected by the findings of chest CT, and diagnosed by the presence of caseating granuloma and/or acid-fast bacilli (AFB) on bronchoscopic biopsv specimens. Mvcobacterium tuberculosis was infiltrations were observed in six patients and atelectasis was noted in two patients of EBTB.
The diagnosis of bronchial asthma was based on the history of wheezing dyspnoea and documented by bronchodilator-induced improvement of FEV,, of more than 20%. Chest PA was normal in all patients with bronchial asthma. Healthy controls were included when they had no respiratory symptoms and a normal chest PA. FVC and FEV, were measured with a computerized spirometer (Fukuda-300, Japan). The provocation concentration of histamine required to reduce the FEV, by 20% of the prechallenge baseline (PC,,) was measured by Cockcroft's method (9) using from 0.025 mg ml -' to 25 mg ml-' of histamine. A dose-response slope was calculated as previously described (10). Bronchial provocation tests with histamine were performed, without medication for 24 h in bronchial asthma patients, and two days before the procedure of bronchoscopy in EBTB patients. The differences between groups were compared using the non-parametric Kruskal-Wallis H-test for continuous data. If found significant, the MannWhitney U-test with Bonferroni's correction was applied to compare any two groups. The relationships between PC,, and physiologic parameters were studied using Spearman's rank correlations. The difference was considered significant when P was less than 0.05. The results were expressed as mean & SE, unless stated otherwise.
Results
FVC and FEV, were matched in EBTB and bronchial asthma. FVC and FEV, were significantly lower in the patients with bronchial asthma and EBTB than normal controls. Age was matched between each group, however females predominated in the EBTB group (Table 1 ). All patients with EBTB had visible endobronchial lesions on bronchoscopy. The four types of EBTB were classified by bronchoscopic findings previously described (11).
PC,, measured in EBTB patients ranged between 1.89-25 mg ml -' with a geometric mean of 17.2 f 2.3 mg ml -' histamine. In the symptomatic patients with bronchial asthma, PC,, ranged between 0.025-5.14 mg ml-' histamine with a geometric mean of 0.99 * 0.15 mg ml -' histamine. PC,, of patients with EBTB was significantly higher than that of patients with bronchial asthma (P<O.Ol). The geometric mean of PC,, in EBTB patients was the same as that of normal controls (17.2 f 2.3 mg ml -' vs. 19.5 + 1.4 mg ml-') ( Fig. 1 ). All normal controls had PC,, greater than 5 mg ml-' histamine, except one case (4.8 mg ml ~ ' histamine). Twelve of 15 patients with EBTB had PC,, greater than 5 mg ml -' histamine. However, all of the patients with symptomatic bronchial asthma, except one patient (5.14 mg ml ~ ' histamine) had concentrations of PC,, lower than 5 mg ml -i histamine. The geometric mean of the dose-response slope of patients with EBTB was not significantly different from that of normal controls (5.6 + 2.5 'vs. 2.1 & 0.6) and was significantly lower than that of patients with bronchial asthma (34.1 * 0.9, PcO.01).
All patients had visible lesions on bronchoscopy. The main locations of EBTB were the trachea and in FVC and FEV,, and the other patient showed minimal improvements. However, no change of PC,, was observed in these patients after treatment, when compared to those before treatment (Table 2) .
Discussion
It was demonstrated that PC,, did not decrease in the patients with EBTB, compared with normal controls. PC,, values were also significantly greater in patients with EBTB and normal controls, than in patients with symptomatic bronchial asthma. This finding suggests that, in patients with cough and wheezing, one should consider the possibility of EBTB for differential diagnosis if airway responsiveness is normal. PC,, has been used to confirm the presence of airway hyperreactivity, which is a hallmark of bronchial asthma (8,9). Of course, patients with other lung diseases including hayfever, chronic bronchitis, emphysema and cystic fibrosis also show airway hyperresponsiveness to non-specific stimuli
Airway responsiveness to non-specific stimuli may arise from bronchial inflammation (12,13). In bronchial asthma, the airway inflammation was diffuse and characterized by epithelial detachment resulting in exposure of epithelial nerves (13). In contrast, airway inflammation was rather focal and limited in EBTB patients when compared with bronchial asthma patients. This focal and localized inflammation in EBTB patients does not seem to increase airway responsiveness to non-specific stimuli. There were some reports that bronchial hyperreactivity might be a manifestation of pulmonary sarcoidosis (14) and pulmonary tuberculosis (15) but the exact mechanism is not known. Some of the patients with pulmonary tuberculosis had low FVC and FEV,, and this might be related to bronchial hyperreactivity. In this study, most patients with EBTB did not have bronchial hyperreactivity, but a few cases had increased bronchial responsiveness. The FEV, values of these patients were above 80% of the predicted value, but the mechanism of increased bronchial hyperresponsiveness is not understood. It may, perhaps, be related to exposure of irritant receptors.
The The patients selected for this study with bronchial asthma, had mild airflow limitation matched with physiologic derangements in EBTB patients. The calibre of the airway can influence the subsequent response to histamine (12). However, the lack of correlation between PC,, and FEV, or types of endobronchial lesion in the patients with EBTB suggest that airway narrowing is not a determinant for PC,, in EBTB. In this study, the ratio of female:male was higher in EBTB than in bronchial asthma and normal control groups. The predominance of females in the EBTB group was reported in the other studies (3,4). As PC,, was not different between the male group and the female group of normal controls in this study (data not shown), sexual difference may not influence PC,, in EBTB.
In conclusion, endobronchial tuberculous inflammation did not increase airway responsiveness. In wheezy patients, one should consider the possibility of EBTB for differential diagnosis if airway responsiveness is normal. 
